tiprankstipranks
Trending News
More News >

BetterLife announces debt conversions

BetterLife (BETRF) Pharma has issued 642,329 common shares and 642,329 share purchase warrants pursuant to the conversion option of convertible debentures and accrued interest on convertible debentures totaling $64,232.88. Share purchase warrants are exercisable into common shares, on a one-for-one basis, at an exercise price of $0.10 per warrant and expire on September 27, 2026 and October 29, 2026.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1